Keiki Sugimoto
Hongo, 1130033, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Label-free ghost cytometry for manufacturing of cell therapy products.
Journal: Scientific reports
Published: October 03, 2023
YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma.
Journal: Pharmacological research
Published: January 16, 2017
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
Journal: Oncotarget
Published: August 15, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.
Journal: Oncotarget
Published: July 10, 2016
Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.
Journal: Scientific reports
Published: April 14, 2016
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells.
Journal: Scientific reports
Published: March 08, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
Journal: The Journal of biological chemistry
Published: January 12, 2015
De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity.
Journal: Cancer science
Published: August 29, 2013
B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026